跳至主要内容
临床试验/NCT03209154
NCT03209154进行中(未招募)不适用

Individualized Blood Pressure Treatment: a Multidisciplinary Approach to Uncontrolled Hypertension in Order to Reduce Morbidity and Mortality

Oslo University Hospital2 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2017年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
1,000
试验地点
2
主要终点
Blood pressure control

研究概览

简要总结

The aim of the study is to investigate and explore the most important aspects of drug-adherence in the treatment of hypertension in order to improve treatment and blood pressure control, implying that new knowledge will reduce morbidity and mortality.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Signed informed consent
  • Uncontrolled hypertension
  • A stable medication regimen for at least 4 weeks of ≥ 2 antihypertensive agents
  • No planned changes in antihypertensive drugs

排除标准

  • Withdrawal of consent
  • 24-h systolic ambulatory blood pressure >/= 170 mmHg
  • Patients with inadequate Norwegian language skills
  • Positive pregnancy test
  • Known alcohol or drug abuse
  • estimated glomerular filtration rate <30 mL/min/1.73m2
  • Albumin/creatinin ratio >300 mg/mmol
  • Any reason why, in the opinion of the investigator, the patient should not participate

结局指标

主要结局

Blood pressure control

时间窗: 3 months after baseline

Change in systolic daytime ambulatory blood pressure.

次要结局

未报告次要终点

研究者

发起方
Oslo University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Sverre Erik Kjeldsen

Professor

Oslo University Hospital

研究点 (2)

Loading locations...

相似试验